ID

22111

Description

The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Mots-clés

Versions (2)
  1. 08/05/2017 08/05/2017 -
  2. 20/05/2017 20/05/2017 -
Téléchargé le

20 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

Anglais

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 Formulaires  
Concomitant Medication
Description

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
Description

Concomitant Medication

Type de données

boolean

Alias
UMLS CUI [1]
C2347852
Medication
Description

Medication

Alias
UMLS CUI-1
C0013227
Drug name (Trade Name preferred) e.g. Aspirin
Description

Drug name

Type de données

text

Alias
UMLS CUI [1]
C0013227
Unit Dose e.g. 200
Description

Unit Dose

Type de données

float

Alias
UMLS CUI [1,1]
C0869039
UMLS CUI [1,2]
C0013227
Units* (eg. mg)
Description

Units

Type de données

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0013227
Frequency* (e.g. BID)
Description

Frequency

Type de données

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C0013227
Route* (e.g. PO)
Description

Route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Reason for Medication (e.g. Headache)
Description

Reason for Medication

Type de données

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
Start Date (e.g. 31 May 03)
Description

Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Start time (e.g. 14:10)
Description

Start time

Type de données

time

Unités de mesure
  • hh:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1301880
hh:min
Taken Prior to Study? (e.g. N)
Description

Taken Prior to Study

Type de données

boolean

Alias
UMLS CUI [1]
C2826667
Stop Date (e.g. 31 May 03)
Description

Stop Date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Stop Time (e.g. 23:00)
Description

Stop Time

Type de données

time

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
Ongoing Medication? (e.g. N)
Description

Ongoing Medication

Type de données

boolean

Alias
UMLS CUI [1]
C2826666
Retour au début de la page

Similar models

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant Medication
Item
Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
boolean
C2347852 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred) e.g. Aspirin
text
C0013227 (UMLS CUI [1])
Unit Dose
Item
Unit Dose e.g. 200
float
C0869039 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Units
Item
Units* (eg. mg)
text
C1519795 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Frequency
Item
Frequency* (e.g. BID)
text
C3476109 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Route
Item
Route* (e.g. PO)
text
C0013153 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Headache)
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Start Date
Item
Start Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Start time
Item
Start time (e.g. 14:10)
time
C0013227 (UMLS CUI [1,1])
C1301880 (UMLS CUI [1,2])
Taken Prior to Study
Item
Taken Prior to Study? (e.g. N)
boolean
C2826667 (UMLS CUI [1])
Stop Date
Item
Stop Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Stop Time
Item
Stop Time (e.g. 23:00)
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Ongoing Medication
Item
Ongoing Medication? (e.g. N)
boolean
C2826666 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial